APPLICATION
NDA215809
TYPE
NDA
ORIGINAL APPROVAL
2022-04-29
LATEST ACTION
2022-04-29
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ERMEZA · ReferencePrescription
LEVOTHYROXINE SODIUM 150MCG/5ML · SOLUTION · ORAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.